Showing results (81-90 of 646) with videos related to
Sort By:
Pageof 65
Hematological Oncology|October 30, 2016
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patientsRaffaella Marcheselli, Alessia Bari, Tamar Tadmor, et al.Leukemia & Lymphoma|December 24, 2015
Bendamustine associated immune suppression and infections during therapy of hematological malignanciesAnat Gafter-Gvili, Aaron PolliackLeukemia & Lymphoma|October 10, 2009
Historical aspects and milestones in the development of effective treatment for hairy cell leukemiaMartin S Tallman, Aaron PolliackHarefuah|March 26, 2023
[HEPATIC MANIFESTATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND CORRELATION WITH PROGNOSIS]Ilana Levy Yurkovski, Yara Shiti, Tamar TadmorHematological Oncology|June 23, 2017
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survivalErel Joffe, N Ariela Arad, Osnat Bairey, et al.Cancer|February 21, 2013
Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implicationsTamar Tadmor, Lev Shvidel, Ariel Aviv, et al.Haematologica|August 13, 2013
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab eraTamar Tadmor, Alessia Bari, Stefano Sacchi, et al.Mayo Clinic Proceedings|June 6, 2015
Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 PatientsTamar Tadmor, Alessia Bari, Luigi Marcheselli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2020
Designing Evolutionary-based Interception Strategies to Block the Transition from Precursor Phases to Multiple MyelomaFrancesco Maura, Ola Landgren, Gareth J MorganBlood|March 29, 2011
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategiesNeha Korde, Sigurdur Y Kristinsson, Ola LandgrenPageof 65